Consilience Ventures

Cerebreon Technologies Ltd., established in 2016 and based in Portnoo, Ireland, specializes in advanced data analytics, business management systems, and process automation. The company develops software solutions for the insolvency market, using machine learning and smart analytics to predict debt recovery outcomes, enhance efficiency, reduce costs, and ensure compliance. Cerebreon caters to businesses of all sizes and sectors, providing bespoke solutions and expert consultancy services to make high-end analytics accessible and beneficial to a wide range of enterprises.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Jiva.ai is an innovative no-code Agentic AI platform designed to empower users from various industries to create, evaluate, and deploy AI agents without requiring programming skills. The company's mission is to democratize AI technology, making it accessible to businesses and entrepreneurs across sectors. Jiva.ai specializes in developing autonomous agents capable of managing tasks such as supply chain monitoring, customer support, and financial portfolio management. The platform supports multimodal AI, allowing for the integration of diverse data types, including imaging, voice, and text. This adaptability has led to its application in sectors like healthcare, marketing optimization, and cybersecurity. Jiva.ai is recognized for its rapid prototyping capabilities, significantly streamlining the AI development process. Its achievements in healthcare, including the creation of high-fidelity diagnostics, highlight its potential to enhance scientific discoveries and clinical outcomes. Jiva.ai's commitment to continuous growth is evidenced by its partnerships with organizations such as MongoDB and IBM HyperProtect, and its recognition as one of the top AI companies in Europe.

Sime Diagnostics Ltd is a clinical AI platform company that specializes in neonatal healthcare, offering innovative solutions to improve patient outcomes in critical care settings. Founded in 2014 and based in London, the company has developed a proprietary software that provides data-driven insights to healthcare professionals, particularly in the neonatal intensive care unit. Their flagship product, the Lung Maturity Test (LMT), predicts Respiratory Distress Syndrome (RDS) in premature infants, allowing for timely interventions that can significantly reduce morbidity and mortality rates. The platform not only aids in real-time disease detection but also curates unique datasets for biomarker discovery, which can benefit both the company and its commercial partners across various medical fields. With a commitment to preventative, personalized medicine, Sime Diagnostics aims to enhance the quality of care through its advanced AI technologies.

Cerebreon Technologies Ltd., established in 2016 and based in Portnoo, Ireland, specializes in advanced data analytics, business management systems, and process automation. The company develops software solutions for the insolvency market, using machine learning and smart analytics to predict debt recovery outcomes, enhance efficiency, reduce costs, and ensure compliance. Cerebreon caters to businesses of all sizes and sectors, providing bespoke solutions and expert consultancy services to make high-end analytics accessible and beneficial to a wide range of enterprises.